NAFLD

Non-alcoholic fatty liver disease, also known as metabolic associated fatty liver disease, is excessive fat build-up in the liver without another clear cause such as alcohol use. There are two types; non-alcoholic fatty liver and non-alcoholic steatohepatitis, with the latter also including liver inflammation. Non-alcoholic fatty liver disease is less dangerous than NASH and usually does not progress to NASH or liver cirrhosis. When NAFLD does progress to NASH, it may eventually lead to complications such as cirrhosis, liver cancer, liver failure, or cardiovascular disease. Obesity and type 2 diabetes are strong risk factors for NAFLD. Other risks include being overweight, metabolic syndrome, a diet high in fructose, and older age. NAFLD and alcoholic liver disease are types of fatty liver disease. Obtaining a sample of the liver after excluding other potential causes of fatty liver can confirm the diagnosis. Treatment for NAFLD is weight loss by dietary changes and exercise.

Read more in the app

New genetic associations in pediatric NAFLD affect both risk and severity

International experts call for a unified public health response to NAFLD and NASH epidemic

CT identifies patients with high-risk nonalcoholic fatty liver disease (NAFLD)